...
首页> 外文期刊>Journal of biomedical nanotechnology >Synthesis of Biodegradable Polymeric Nanoparticles and Their Controlled Drug Delivery for Tuberculosis
【24h】

Synthesis of Biodegradable Polymeric Nanoparticles and Their Controlled Drug Delivery for Tuberculosis

机译:可生物降解的高分子纳米颗粒的合成及其对肺结核的控制药物传递

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberculosis (TB) is the leading cause of infectious diseases affecting the 2 billion people worldwide. To improve the current method of treatment a synthetic polymeric anti-TB nanodrug delivery system was attempted. A series of PLGA polymers with different molar feed ratios i.e., 90/10, 75/25, 50/50 were synthesized by direct melt polycondensation method. The PLGA nanoparticles and the drug ( Rifampicin (RIF)) encapsulation were prepared by double emulsion–solvent evaporation technique. The in vitro release profile of the RIF loaded PLGA NPs showed an initial burst followed by sustained release. The nanoparticles were remarkably advantageous in terms of high drug encapsulation efficiency, low polymer consumption and better sustained release profile.
机译:结核病(TB)是影响全球20亿人口的传染病的主要原因。为了改善当前的治疗方法,尝试了合成聚合物抗结核纳米药物递送系统。通过直接熔融缩聚法合成了具有不同摩尔进料比即90 / 10、75 / 25、50 / 50的一系列PLGA聚合物。 PLGA纳米颗粒和药物(利福平(RIF))的封装是通过双重乳液-溶剂蒸发技术制备的。装有RIF的PLGA NP的体外释放曲线显示出最初的爆发,随后是持续释放。就高药物包封效率,低聚合物消耗和更好的持续释放特性而言,纳米颗粒是非常有利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号